178 related articles for article (PubMed ID: 38499860)
1. Targeting initial tumour-osteoclast spatiotemporal interaction to prevent bone metastasis.
Gu C; Chen P; Tian H; Yang Y; Huang Z; Yan H; Tang C; Xiang J; Shangguan L; Pan K; Chen P; Huang Y; Liu Z; Tang R; Fan S; Lin X
Nat Nanotechnol; 2024 Mar; ():. PubMed ID: 38499860
[TBL] [Abstract][Full Text] [Related]
2. Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.
Liu B; Yang Q; Cheng Y; Liu M; Ji Q; Zhang B; Yang Z; Zhou S; Liu D
Acta Biomater; 2023 Aug; 166():640-654. PubMed ID: 37236576
[TBL] [Abstract][Full Text] [Related]
3. Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo.
Brown HK; Ottewell PD; Evans CA; Holen I
Clin Exp Metastasis; 2012 Dec; 29(8):927-38. PubMed ID: 22562502
[TBL] [Abstract][Full Text] [Related]
4. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
5. Use of oxygen-loaded nanobubbles to improve tissue oxygenation: Bone-relevant mechanisms of action and effects on osteoclast differentiation.
Knowles HJ; Vasilyeva A; Sheth M; Pattinson O; May J; Rumney RMH; Hulley PA; Richards DB; Carugo D; Evans ND; Stride E
Biomaterials; 2024 Mar; 305():122448. PubMed ID: 38218121
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates.
Ciapetti G; Di Pompo G; Avnet S; Martini D; Diez-Escudero A; Montufar EB; Ginebra MP; Baldini N
Acta Biomater; 2017 Mar; 50():102-113. PubMed ID: 27940198
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to target the microenvironment of bone metastasis.
Hofbauer LC; Bozec A; Rauner M; Jakob F; Perner S; Pantel K
Nat Rev Clin Oncol; 2021 Aug; 18(8):488-505. PubMed ID: 33875860
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium phosphate phases affecting the crosstalk between osteoblasts and osteoclasts in vitro.
Shiwaku Y; Tsuchiya K; Xiao L; Suzuki O
J Biomed Mater Res A; 2019 May; 107(5):1001-1013. PubMed ID: 30684383
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
[TBL] [Abstract][Full Text] [Related]
10. Smart Nanosacrificial Layer on the Bone Surface Prevents Osteoporosis through Acid-Base Neutralization Regulated Biocascade Effects.
Lin X; Wang Q; Gu C; Li M; Chen K; Chen P; Tang Z; Liu X; Pan H; Liu Z; Tang R; Fan S
J Am Chem Soc; 2020 Oct; 142(41):17543-17556. PubMed ID: 32960592
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation.
Qin Y; Yang J; Liang C; Liu J; Deng Z; Yan B; Fu Y; Luo Y; Li X; Wei X; Li W
Front Immunol; 2022; 13():994828. PubMed ID: 36405728
[TBL] [Abstract][Full Text] [Related]
12. Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis.
Zheng Y; Zhou H; Fong-Yee C; Modzelewski JR; Seibel MJ; Dunstan CR
Clin Exp Metastasis; 2008; 25(5):559-67. PubMed ID: 18421566
[TBL] [Abstract][Full Text] [Related]
13. Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases.
Xu Q; Cao Z; Xu J; Dai M; Zhang B; Lai Q; Liu X
J Drug Target; 2022 Apr; 30(4):394-412. PubMed ID: 34859718
[TBL] [Abstract][Full Text] [Related]
14. Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences.
Heymann D
J Bone Oncol; 2012 Jun; 1(1):2-11. PubMed ID: 26909248
[TBL] [Abstract][Full Text] [Related]
15. The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging.
Wang S; Niu X; Bao X; Wang Q; Zhang J; Lu S; Wang Y; Xu L; Wang M; Zhang J
Oncol Rep; 2019 May; 41(5):2636-2646. PubMed ID: 30896825
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration.
Moreaux J; Hose D; Kassambara A; Reme T; Moine P; Requirand G; Goldschmidt H; Klein B
Blood; 2011 Jan; 117(4):1280-90. PubMed ID: 21097672
[TBL] [Abstract][Full Text] [Related]
17. Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.
Kong D; Ye C; Zhang C; Sun X; Wang F; Chen R; Xiao G; He S; Xu J; Rao X; Ai J; Gao X; Li H; Su L
J Exp Clin Cancer Res; 2023 Feb; 42(1):45. PubMed ID: 36759880
[TBL] [Abstract][Full Text] [Related]
18. Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.
Sheraly AR; Lickorish D; Sarraf F; Davies JE
Curr Drug Deliv; 2009 Apr; 6(2):192-8. PubMed ID: 19450226
[TBL] [Abstract][Full Text] [Related]
19. Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat.
Thompson ER; Baylink DJ; Wergedal JE
Endocrinology; 1975 Aug; 97(2):283-9. PubMed ID: 1157752
[TBL] [Abstract][Full Text] [Related]
20. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
